Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer.Gene Techno Science was founded in 2001 and is headquartered in Sapporo, Japan.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 7, 2010 | Series Unknown | ¥507.90M | 1 | — | — | Detail |
Jun 11, 2008 | Series Unknown | ¥500.25M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Daiwa SMBC Capital | — | Series Unknown |
Bio-sight Capital | — | Series Unknown |
Nomura Research and Advisory | — | Series Unknown |
NIF SMBC Ventures | — | Series Unknown |